Moreover, high GLUT3 expression had a significant effect on the overall and disease-specific survival of patients with GI tumors, but the effect on the disease-free and progression-free survival of these patients was no significant (Additional file 1: Figure S1 C–F). Here, SLC2A3 is linked to digestive system neoplasm.